(1S)-(+)-Neomenthyl acetate,
2552-91-2,
Neomenthyl acetate,
d-Neomenthyl acetate,
(+)-Neomenthyl acetate,
mentyl acetate,
Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate, (1S,2S,5R)-,
NSC 7350,
EINECS 219-856-3,
NEOMENTHYLACETATE,
Menthol, acetate, (1R,3S,4S)-(+)-,
AC1L2PBV,
AC1Q5WYG,
(1S)-neomenthyl acetate,
AC1Q1NQ0,
SCHEMBL4256862,
Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 1-acetate, (1S,2S,5R)-,
CHEBI:80758,
CTK8F1611,
ZINC4521484,
FCH920429,
AKOS006343703,
(+)-(1S,2S,5R)-Neomenthyl acetate,
FT-0694110,
C16825,
C-47120,
(1S,2S,5R)-2-isopropyl-5-methylcyclohexyl acetate,
I14-45359,
[(1S,2S,5R)-2-isopropyl-5-methyl-cyclohexyl] acetate,
[(1S,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl] acetate,
Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate, (1S-(1alpha,2alpha,5beta))-,
(1S,2S,5R)-(+)-Neomenthyl acetate, puriss. p.a., terpene standard for GC, >=99.0% (sum of enantiomers, GC),
Bromocolchicine,
C22H24BrNO6,
(1S)-(+)-Neomenthylacetate,
C22-H24-Br-N-O6,
KST-1A3266,
CID75699,
AR-1A1362,
C12-H22-O2,
Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate (8CI),
26195-69-7,
Cyclohexanol,5-methyl-2-(1-methylethyl)-,acetate,(1R,2R,5S)-rel-,
Cyclohexanol, 5-methyl-2-(1-methylethyl)-, acetate, [1S-(1.alpha.,2.alpha.,5.beta.)]-,
2230-87-7,